TNT for organ preservation in rectal cancer: still looking for the right schedule and patient

被引：0
作者：
Grotenhuis, B. A. [1 ]
Couwenberg, A. M. [2 ]
Marijnen, C. A. M. [2 ,3 ]
机构：
[1] Netherlands Canc Inst Antoni van Leeuwenhoek, Dept Surg Oncol, Amsterdam, Netherlands
[2] Netherlands Canc Inst Antoni van Leeuwenhoek, Dept Radiat Oncol, Amsterdam, Netherlands
[3] Leiden Univ, Med Ctr, Dept Radiat Oncol, Leiden, Netherlands
来源：
ANNALS OF ONCOLOGY | 2024年 / 35卷 / 11期
关键词：
PREOPERATIVE CHEMORADIOTHERAPY; OPEN-LABEL; CHEMOTHERAPY; MULTICENTER;
D O I：
10.1016/j.annonc.2024.09.014
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：928 / 929
页数：2
相关论文
共 12 条
  • [1] Alliance A022104/NRG-GI010: The Janus Rectal Cancer Trial: a randomized phase II/III trial testing the efficacy of triplet versus doublet chemotherapy regarding clinical complete response and disease-free survival in patients with locally advanced rectal cancer
    Alvarez, Janet A.
    Shi, Qian
    Dasari, Arvind
    Garcia-Aguilar, Julio
    Sanoff, Hanna
    George, Thomas J.
    Hong, Theodore
    Yothers, Greg
    Philip, Philip
    Nelson, Garth
    Al Baghdadi, Tareq
    Alese, Olatunji B.
    Zambare, Wini
    Omer, Dana
    Verheij, Floris S.
    Bercz, Aron
    Kim, Min Jung
    Buckley, James
    Williams, Hannah
    George, Manju
    Garcia, Reese
    Gallagher, Phuong
    O'Reilly, Eileen M.
    Meyerhardt, Jeffrey A.
    Crawley, Jamie
    Shergill, Ardaman
    Horvat, Natally
    Romesser, Paul B.
    Hall, William
    Smith, J. Joshua
    [J]. BMC CANCER, 2024, 24 (01)
  • [2] Can we Save the rectum by watchful waiting or TransAnal surgery following (chemo)Radiotherapy versus Total mesorectal excision for early REctal Cancer (STAR-TREC)? Protocol for the international, multicentre, rolling phase II/IIII partially randomized patient preference trial evaluating long-course concurrent chemoradiotherapy versus short-course radiotherapy organ preservation approaches
    Bach, Simon P.
    [J]. COLORECTAL DISEASE, 2022, 24 (05) : 639 - 651
  • [3] Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial
    Bahadoer, Renu R.
    Dijkstra, Esmee A.
    van Etten, Boudewijn
    Marijnen, Corrie A. M.
    Putter, Hein
    Kranenbarg, Elma Meershoek-Klein
    Roodvoets, Annet G. H.
    Nagtegaal, Iris D.
    Beets-Tan, Regina G. H.
    Blomqvist, Lennart K.
    Fokstuen, Tone
    ten Tije, Albert J.
    Capdevila, Jaume
    Hendriks, Mathijs P.
    Edhemovic, Ibrahim
    Cervantes, Andres
    Nilsson, Per J.
    Glimelius, Bengt
    van de Velde, Cornelis J. H.
    Hospers, Geke A. P.
    [J]. LANCET ONCOLOGY, 2021, 22 (01) : 29 - 42
  • [4] Organ preservation after neoadjuvant long-course chemoradiotherapy versus short-course radiotherapy
    Bercz, A.
    Park, B. K.
    Pappou, E.
    Nemirovsky, D.
    Sarkar, R.
    Yamner, M.
    Omer, D.
    Verheij, F. S.
    Alvarez, J.
    Atri, P.
    Reyngold, M.
    Yaeger, R.
    Wei, I. H.
    Wu, A.
    Raj, N.
    Widmar, M.
    Hajj, C.
    Kim, M. J.
    Rao, D.
    Nash, G. M.
    Williams, V.
    Shia, J.
    Segal, N. H.
    Diaz, L.
    Ganesh, K.
    Weiser, M. R.
    Gollub, M. J.
    Paty, P. B.
    Horvat, N.
    Zinovoy, M.
    O'Brien, D. Roth
    Sanchez-Vega, F.
    Saltz, L. B.
    Crane, C. H.
    Cercek, A.
    Gonen, M.
    Garcia-Aguilar, J.
    Smith, J. J.
    Romesser, P. B.
    [J]. ANNALS OF ONCOLOGY, 2024, 35 (11) : 1003 - 1014
  • [5] Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23) : a multicentre, randomised, open-label, phase 3 trial
    Conroy, Thierry
    Bosset, Jean-Francois
    Etienne, Pierre-Luc
    Rio, Emmanuel
    Francois, Eric
    Mesgouez-Nebout, Nathalie
    Vendrely, Veronique
    Artignan, Xavier
    Bouche, Olivier
    Gargot, Dany
    Boige, Valerie
    Bonichon-Lamichhane, Nathalie
    Louvet, Christophe
    Morand, Clotilde
    de la Fouchardiere, Christelle
    Lamfichekh, Najib
    Juzyna, Beata
    Jouffroy-Zeller, Claire
    Rullier, Eric
    Marchal, Frederic
    Gourgou, Sophie
    Castan, Florence
    Borg, Christophe
    [J]. LANCET ONCOLOGY, 2021, 22 (05) : 702 - 715
  • [6] Fokas E, 2022, JAMA Oncol., P1
  • [7] Organ Preservation in Patients With Rectal Adenocarcinoma Treated With Total Neoadjuvant Therapy
    Garcia-Aguilar, Julio
    Patil, Sujata
    Gollub, Marc J.
    Kim, Jin K.
    Yuval, Jonathan B.
    Thompson, Hannah M.
    Verheij, Floris S.
    Omer, Dana M.
    Lee, Meghan
    Dunne, Richard F.
    Marcet, Jorge
    Cataldo, Peter
    Polite, Blase
    Herzig, Daniel O.
    Liska, David
    Oommen, Samuel
    Friel, Charles M.
    Ternent, Charles
    Coveler, Andrew L.
    Hunt, Steven
    Gregory, Anita
    Varma, Madhulika G.
    Bello, Brian L.
    Carmichael, Joseph C.
    Krauss, John
    Gleisner, Ana
    Paty, Philip B.
    Weiser, Martin R.
    Nash, Garrett M.
    Pappou, Emmanouil
    Guillem, Jose G.
    Temple, Larissa
    Wei, Iris H.
    Widmar, Maria
    Lin, Sabrina
    Segal, Neil H.
    Cercek, Andrea
    Yaeger, Rona
    Smith, J. Joshua
    Goodman, Karyn A.
    Wu, Abraham J.
    Saltz, Leonard B.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (23) : 2546 - +
  • [8] Neoadjuvant chemoradiotherapy with radiation dose escalation with contact x-ray brachytherapy boost or external beam radiotherapy boost for organ preservation in early cT2-cT3 rectal adenocarcinoma (OPERA): a phase 3 randomised controlled trial
    Gerard, Jean-Pierre
    Barbet, Nicolas
    Schiappa, Renaud
    Magne, Nicolas
    Martel, Isabelle
    Mineur, Laurent
    Deberne, Melanie
    Zilli, Thomas
    Dhadda, Amandeep
    Myint, Arthur Sun
    [J]. LANCET GASTROENTEROLOGY & HEPATOLOGY, 2023, 8 (04): : 356 - 367
  • [9] Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
    Glynne-Jones, R.
    Wyrwicz, L.
    Tiret, E.
    Brown, G.
    Rodel, C.
    Cervantes, A.
    Arnold, D.
    [J]. ANNALS OF ONCOLOGY, 2017, 28 : 22 - 40
  • [10] Validated Pretreatment Prediction Models for Response to Neoadjuvant Therapy in Patients with Rectal Cancer: A Systematic Review and Critical Appraisal
    Tanaka, Max D.
    Geubels, Barbara M.
    Grotenhuis, Brechtje A.
    Marijnen, Corrie A. M.
    Peters, Femke P.
    Van der Mierden, Stevie
    Maas, Monique
    Couwenberg, Alice M.
    [J]. CANCERS, 2023, 15 (15)
12